{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:59:41Z","timestamp":1790089181696,"version":"4.0.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK12570"],"award-info":[{"award-number":["R01 DK12570"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NR019083"],"award-info":[{"award-number":["NR019083"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K24 HL171937"],"award-info":[{"award-number":["K24 HL171937"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR001108"],"award-info":[{"award-number":["UL1 TR001108"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000454"],"award-info":[{"award-number":["UL1TR000454"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000448"],"award-info":[{"award-number":["UL1TR000448"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002378"],"award-info":[{"award-number":["UL1TR002378"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061718"],"award-info":[{"award-number":["U01DK061718"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["5U01DK061737U24DK061730"],"award-info":[{"award-number":["5U01DK061737U24DK061730"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061731"],"award-info":[{"award-number":["U01DK061731"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK061730"],"award-info":[{"award-number":["U01DK061730"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jhepr.2026.102016","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:50:58Z","timestamp":1788069058000},"page":"102016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and Metabolomic Panel for Noninvasive Screening of Biopsy-Confirmed MASH in Children and Adolescents"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3866-2387","authenticated-orcid":false,"given":"Helaina E.","family":"Huneault","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrramana Ganesh","family":"Sudhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7429-3828","authenticated-orcid":false,"given":"Alasdair E.","family":"Gent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4670-1497","authenticated-orcid":false,"given":"Zachery R.","family":"Jarrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8889-3477","authenticated-orcid":false,"given":"Matthew Ryan","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Sanchez-Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6138-2194","authenticated-orcid":false,"given":"Katherine P.","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8520-7398","authenticated-orcid":false,"given":"Brent A.","family":"Neuschwander-Tetri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8538-2877","authenticated-orcid":false,"given":"Jeffrey B.","family":"Schwimmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavra A.","family":"Xanthakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8708-0298","authenticated-orcid":false,"given":"Jean P.","family":"Molleston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Behling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8366-4811","authenticated-orcid":false,"given":"Rishikesan","family":"Kamaleswaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam B.","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jhepr.2026.102016_bib1","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1542\/peds.2006-1212","article-title":"Prevalence of fatty liver in children and adolescents","volume":"118","author":"Schwimmer","year":"2006","journal-title":"Pediatrics"},{"issue":"7","key":"10.1016\/j.jhepr.2026.102016_bib2","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1053\/j.gastro.2020.01.048","article-title":"Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges","volume":"158","author":"Goldner","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.jhepr.2026.102016_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MPG.0000000000003795","article-title":"Prevalence of Elevated ALT in Adolescents in the US 2011\u20132018","volume":"77","author":"Mischel","year":"2023","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"10.1016\/j.jhepr.2026.102016_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpeds.2018.11.021","article-title":"Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity","volume":"207","author":"Yu","year":"2019","journal-title":"J Pediatr"},{"issue":"6","key":"10.1016\/j.jhepr.2026.102016_bib5","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhepr.2026.102016_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.25122\/jml-2022-0091","article-title":"Non-alcoholic fatty liver disease: relation to juvenile obesity, lipid profile, and hepatic enzymes","volume":"16","author":"Altalebi","year":"2023","journal-title":"J Med Life"},{"issue":"1","key":"10.1016\/j.jhepr.2026.102016_bib7","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00431-024-05848-1","article-title":"Pediatric MASLD: current understanding and practical approach","volume":"184","author":"Stroes","year":"2024","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1016\/j.jhepr.2026.102016_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.20842","article-title":"Histopathology of pediatric nonalcoholic fatty liver disease","volume":"42","author":"Schwimmer","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.102016_bib9","doi-asserted-by":"crossref","unstructured":"Pardee PE, Lavine JE, Schwimmer JB. Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery. Elsevier; 2009:144\u2013151.","DOI":"10.1053\/j.sempedsurg.2009.04.004"},{"issue":"10S","key":"10.1016\/j.jhepr.2026.102016_bib10","doi-asserted-by":"crossref","first-page":"S1316","DOI":"10.14309\/01.ajg.0001036672.48353.6c","article-title":"S1826 Prevalence of Metabolic-Associated Steatohepatitis (MASH) and Advanced Fibrosis in At-Risk Pediatric Populations","volume":"119","author":"Kim","year":"2024","journal-title":"Official journal of the American College of Gastroenterology | ACG."},{"key":"10.1016\/j.jhepr.2026.102016_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.obpill.2025.100164","article-title":"Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025","volume":"14","author":"Panganiban","year":"2025","journal-title":"Obesity Pillars"},{"issue":"4","key":"10.1016\/j.jhepr.2026.102016_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MCG.0000000000000925","article-title":"Nonalcoholic Steatohepatitis is the Most Rapidly Increasing Indication for Liver Transplantation in Young Adults in the United States","volume":"52","author":"Doycheva","year":"2018","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhepr.2026.102016_bib13","doi-asserted-by":"crossref","unstructured":"Rinella ME, Tacke F, Sanyal AJ, Anstee QM. Report on the AASLD\/EASL Joint Workshop on Clinical Trial Endpoints in NAFLD. Hepatology. Jul 9 2019;doi:10.1002\/hep.30782","DOI":"10.1002\/hep.30782"},{"key":"10.1016\/j.jhepr.2026.102016_bib14","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and Validation of a Histological Scoring System for Nonalcoholic Fatty Liver Disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.jhepr.2026.102016_bib15","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1053\/j.gastro.2005.03.084","article-title":"Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease","volume":"128","author":"Ratziu","year":"2005","journal-title":"Gastroenterology"},{"issue":"Suppl 4","key":"10.1016\/j.jhepr.2026.102016_bib16","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1542\/peds.2007-2329C","article-title":"Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Journal Article","volume":"120","author":"Barlow","year":"2007","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.jhepr.2026.102016_bib17","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1053\/j.gastro.2009.12.052","article-title":"SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Journal Article Research Support N I H Extramural","volume":"138","author":"Schwimmer","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.102016_bib18","article-title":"Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease","author":"Schwimmer","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.102016_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/hep.27808","article-title":"Is it time to advance pediatric NAFLD diagnosis to the magnetic resonance imaging era?","author":"Vos","year":"2015","journal-title":"Hepatology"},{"issue":"16","key":"10.1016\/j.jhepr.2026.102016_bib20","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial","volume":"305","author":"Lavine","year":"2011","journal-title":"Jama"},{"key":"10.1016\/j.jhepr.2026.102016_bib21","article-title":"Data from: Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Database (V4)","author":"Tonascia","year":"2024","journal-title":"NIDDK Central Repository"},{"issue":"6","key":"10.1016\/j.jhepr.2026.102016_bib22","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1053\/j.gastro.2008.08.050","article-title":"Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis","volume":"135","author":"Patton","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2026.102016_bib23","unstructured":"(NIDDK) NIoDaDaKD. NAFLD Pediatric Database 2. Accessed September 26, 2024, https:\/\/repository.niddk.nih.gov\/studies\/nafld-pediatric-database-2\/"},{"issue":"2","key":"10.1016\/j.jhepr.2026.102016_bib24","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ejcn.2012.203","article-title":"BMI percentiles for the identification of abdominal obesity and metabolic risk in children and adolescents: evidence in support of the CDC 95th percentile","volume":"67","author":"Harrington","year":"2013","journal-title":"European Journal of Clinical Nutrition"},{"issue":"16","key":"10.1016\/j.jhepr.2026.102016_bib25","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.2011.520","article-title":"Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents: The TONIC Randomized Controlled Trial","volume":"305","author":"Lavine","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.jhepr.2026.102016_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem."},{"issue":"7","key":"10.1016\/j.jhepr.2026.102016_bib27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.jhepr.2026.102016_bib28","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2026.102016_bib29","first-page":"259A","article-title":"Comparison of adult and pediatric NAFLD\u2014confirmation of a second pattern of progressive fatty liver disease in children: 189","volume":"44","author":"Kleiner","year":"2006","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.jhepr.2026.102016_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12565","article-title":"Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease","volume":"2","author":"Kleiner","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"13","key":"10.1016\/j.jhepr.2026.102016_bib31","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1021\/acs.analchem.0c00338","article-title":"Reference Standardization for Quantification and Harmonization of Large-Scale Metabolomics","volume":"92","author":"Liu","year":"2020","journal-title":"Anal Chem"},{"key":"10.1016\/j.jhepr.2026.102016_bib32","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.taap.2018.12.001","article-title":"Metabolome-wide association study of anti-epileptic drug treatment during pregnancy","volume":"363","author":"Walker","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"issue":"8","key":"10.1016\/j.jhepr.2026.102016_bib33","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1097\/JOM.0000000000000773","article-title":"High-Resolution Metabolomics Assessment of Military Personnel: Evaluating Analytical Strategies for Chemical Detection","volume":"58","author":"Liu","year":"2016","journal-title":"Journal of Occupational and Environmental Medicine"},{"issue":"15","key":"10.1016\/j.jhepr.2026.102016_bib34","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/bioinformatics\/btp291","article-title":"apLCMS--adaptive processing of high-resolution LC\/MS data","volume":"25","author":"Yu","year":"2009","journal-title":"Bioinformatics"},{"issue":"1","key":"10.1016\/j.jhepr.2026.102016_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2105-14-15","article-title":"xMSanalyzer: automated pipeline for improved feature detection and downstream analysis of large-scale, non-targeted metabolomics data","volume":"14","author":"Uppal","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.jhepr.2026.102016_bib36","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","article-title":"Adjusting batch effects in microarray expression data using empirical Bayes methods","volume":"8","author":"Johnson","year":"2007","journal-title":"Biostatistics"},{"issue":"2","key":"10.1016\/j.jhepr.2026.102016_bib37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/toxsci\/kfv198","article-title":"Reference Standardization for Mass Spectrometry and High-resolution Metabolomics Applications to Exposome Research","volume":"148","author":"Go","year":"2015","journal-title":"Toxicological Sciences"},{"issue":"3","key":"10.1016\/j.jhepr.2026.102016_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","article-title":"Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI)","volume":"3","author":"Sumner","year":"2007","journal-title":"Metabolomics"},{"issue":"2","key":"10.1016\/j.jhepr.2026.102016_bib39","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1021\/acs.analchem.6b01214","article-title":"xMSannotator: An R Package for Network-Based Annotation of High-Resolution Metabolomics Data","volume":"89","author":"Uppal","year":"2017","journal-title":"Anal Chem"},{"key":"10.1016\/j.jhepr.2026.102016_bib40","doi-asserted-by":"crossref","unstructured":"Berger VW, Zhou Y. Kolmogorov\u2013smirnov test: Overview. Wiley statsref: Statistics reference online. 2014;","DOI":"10.1002\/9781118445112.stat06558"},{"key":"10.1016\/j.jhepr.2026.102016_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.chroma.2015.05.025","article-title":"Least absolute shrinkage and selection operator and dimensionality reduction techniques in quantitative structure retention relationship modeling of retention in hydrophilic interaction liquid chromatography","volume":"1403","author":"Daghir-Wojtkowiak","year":"2015","journal-title":"Journal of Chromatography A"},{"issue":"1","key":"10.1016\/j.jhepr.2026.102016_bib42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40537-020-00369-8","article-title":"CatBoost for big data: an interdisciplinary review","volume":"7","author":"Hancock","year":"2020","journal-title":"Journal of big data"},{"issue":"1","key":"10.1016\/j.jhepr.2026.102016_bib43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40537-024-00905-w","article-title":"Feature selection strategies: a comparative analysis of SHAP-value and importance-based methods","volume":"11","author":"Wang","year":"2024","journal-title":"Journal of Big Data"},{"key":"10.1016\/j.jhepr.2026.102016_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2019.154005","article-title":"Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study","volume":"101","author":"Perakakis","year":"2019","journal-title":"Metabolism"},{"issue":"10","key":"10.1016\/j.jhepr.2026.102016_bib45","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/hep4.1417","article-title":"Development of a Plasma Screening Panel for Pediatric Nonalcoholic Fatty Liver Disease Using Metabolomics","volume":"3","author":"Khusial","year":"2019","journal-title":"Hepatol Commun"},{"issue":"3","key":"10.1016\/j.jhepr.2026.102016_bib46","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000375","article-title":"Validation of a screening panel for pediatric metabolic dysfunction-associated steatotic liver disease using metabolomics","volume":"8","author":"Huneault","year":"2024","journal-title":"Hepatol Commun"},{"issue":"5","key":"10.1016\/j.jhepr.2026.102016_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/hep.29393","article-title":"Magnetic resonance elastography assessment of fibrosis in children with NAFLD: Promising but not perfect","volume":"66","author":"Xanthakos","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jhepr.2026.102016_bib48","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jpeds.2013.07.050","article-title":"Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease","volume":"164","author":"Xanthakos","year":"2014","journal-title":"The Journal of pediatrics"},{"issue":"1","key":"10.1016\/j.jhepr.2026.102016_bib49","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/HEP.0000000000000542","article-title":"Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF)","volume":"79","author":"Noureddin","year":"2024","journal-title":"Hepatology"},{"issue":"9","key":"10.1016\/j.jhepr.2026.102016_bib50","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/neuonc\/nox242","article-title":"The FDA NIH Biomarkers, EndpointS, and other Tools (BEST) resource in neuro-oncology","volume":"20","author":"Cagney","year":"2017","journal-title":"Neuro-Oncology"},{"issue":"9","key":"10.1016\/j.jhepr.2026.102016_bib51","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/liv.12226","article-title":"Predictive value of ALT levels for non\u2010alcoholic steatohepatitis (NASH) and advanced fibrosis in non\u2010alcoholic fatty liver disease (NAFLD)","volume":"33","author":"Verma","year":"2013","journal-title":"Liver International"},{"issue":"8","key":"10.1016\/j.jhepr.2026.102016_bib52","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1136\/gutjnl-2023-331401","article-title":"MASH Resolution Index: development and validation of a non-invasive score to detect histological resolution of MASH","volume":"73","author":"Loomba","year":"2024","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.jhepr.2026.102016_bib53","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cmet.2024.10.008","article-title":"A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis","volume":"37","author":"Zhang","year":"2025","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.jhepr.2026.102016_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2024.100737","article-title":"Biomarkers of Hepatic Toxicity: An Overview","volume":"100","author":"Thakur","year":"2024","journal-title":"Current Therapeutic Research."},{"issue":"4","key":"10.1016\/j.jhepr.2026.102016_bib55","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/172460080401900411","article-title":"Clinical significance of urinary N1,N12-diacetylspermine levels in patients with hepatocellular carcinoma","volume":"19","author":"Enjoji","year":"2004","journal-title":"Int J Biol Markers"},{"issue":"5","key":"10.1016\/j.jhepr.2026.102016_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051450","article-title":"Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance","volume":"12","author":"Hasegawa","year":"2020","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.jhepr.2026.102016_bib57","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1111\/jgh.16603","article-title":"Role of ammonia and glutamine in the pathogenesis and progression of metabolic dysfunction-associated steatotic liver disease: A systematic review","volume":"39","author":"Njei","year":"2024","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"1","key":"10.1016\/j.jhepr.2026.102016_bib58","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/livers2010003","article-title":"Oxidative Stress in Non-Alcoholic Fatty Liver Disease","volume":"2","author":"Smirne","year":"2022","journal-title":"Livers"},{"key":"10.1016\/j.jhepr.2026.102016_bib59","first-page":"69doi","article-title":"Urea cycle dysregulation in non-alcoholic fatty liver disease","author":"Chiara","year":"2018","journal-title":"Journal of Hepatology"},{"issue":"9","key":"10.1016\/j.jhepr.2026.102016_bib60","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.cmet.2024.07.007","article-title":"Hierarchical tricarboxylic acid cycle regulation by hepatocyte arginase 2 links the urea cycle to oxidative metabolism","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metabolism"},{"issue":"3","key":"10.1016\/j.jhepr.2026.102016_bib61","article-title":"Changes in Glutathione Content in Liver Diseases: An Update","volume":"10","author":"Vairetti","year":"2021","journal-title":"Antioxidants (Basel)"},{"issue":"9","key":"10.1016\/j.jhepr.2026.102016_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23095146","article-title":"Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis","volume":"23","author":"Brankovi\u0107","year":"2022","journal-title":"Int J Mol Sci."},{"issue":"1","key":"10.1016\/j.jhepr.2026.102016_bib63","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1194\/jlr.M700184-JLR200","article-title":"Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes","volume":"49","author":"Han","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhepr.2026.102016_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105088","article-title":"Emerging role of ferroptosis in metabolic dysfunction-associated steatotic liver disease: revisiting hepatic lipid peroxidation","volume":"102","author":"Peleman","year":"2024","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.jhepr.2026.102016_bib65","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1177\/00045632241259658","article-title":"Increased phosphatidylcholine and its hydroperoxides in serum low-density lipoproteins from patients with non-alcoholic steatohepatitis","volume":"61","author":"Murakami","year":"2024","journal-title":"Annals of Clinical Biochemistry"},{"issue":"1","key":"10.1016\/j.jhepr.2026.102016_bib66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/joim.12892","article-title":"Indoles: metabolites produced by intestinal bacteria capable of controlling liver disease manifestation","volume":"286","author":"Hendrikx","year":"2019","journal-title":"Journal of Internal Medicine"},{"issue":"4","key":"10.1016\/j.jhepr.2026.102016_bib67","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s42255-023-00775-1","article-title":"A proteo-transcriptomic map of non-alcoholic fatty liver disease signatures","volume":"5","author":"Govaere","year":"2023","journal-title":"Nat Metab"},{"issue":"2","key":"10.1016\/j.jhepr.2026.102016_bib68","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1021\/acs.jproteome.5c00749","article-title":"Correlation of Plasma and Liver Tissue Proteomics for Plasma Biomarkers in Metabolic Dysfunction-Associated Steatotic Liver Disease","volume":"25","author":"Sourianarayanane","year":"2026","journal-title":"J Proteome Res"},{"issue":"4","key":"10.1016\/j.jhepr.2026.102016_bib69","first-page":"255","article-title":"Overview of Metabolic Dysfunction-Associated Steatohepatitis in Children","volume":"21","author":"Kohli","year":"2025","journal-title":"Gastroenterol Hepatol (N Y)."}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926002879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555926002879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:59:36Z","timestamp":1790085576000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555926002879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":69,"alternative-id":["S2589555926002879"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.102016","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Metabolomic Panel for Noninvasive Screening of Biopsy-Confirmed MASH in Children and Adolescents","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2026.102016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"102016"}}